ªvG¨`¼ö½è¤l¬¦§í¨î¾¯ ªøªA¥iP°©§éµÇ¯f
¡i©ú³ø±M°T¡j¤@¨ÇÂå¥Í»¡¡M¼Æ¥H¦Ê¸Up¥[®³¤j¤Hªø´ÁªA¥Î³B¤èÃĪ«¡Mªv²zG¨`¼ö¡M¨ä¹ê«Ü¦h¤H¨S¦³ªø´ÁªAÃĪº»Ýn¡M¦]¬°¨º·|²£¥Í¤£¤Ö°Æ§@¥Î¡C³oÃþÃĪ«¦W¬°½è¤l¬¦§í¨î¾¯(proton pump inhibitors)¡M¥]¬A¶ø¬ü©ÔÐü(omeprazole¡M¤S¦W¬¥ÁɧJLosec)¡B®J¯Á¬ü©ÔÐü(esomeprazole¡M¤S¦W@«HNexium)¡BÄõ¯Á©ÔÐü(Lansoprazole¡M¤S¦WPrevacid)¡M¥H¤Î«D³B¤èÃĪ«Olex¡C½è¤l¬¦§í¨î¾¯°§CG»Ä¤Àªc¡M´î»´G¯f¯gª¬¡C
¥[°ê½Ã¥Í³¡©M¬ü°ê¹«~¤ÎÃĪ«ºÞ²z§½(U.S. Food and Drug Administration)´£¿ô¥Á²³¡M¦pnªA¥Î½è¤l¬¦§í¨î¾¯¡MºÉ¶qµu´ÁªA¥Î¡M¥ç§Y´XÓ¬P´Á¡C³oºØÃĪ«¥u¾A©yªvÀøÄY«G»Äˬy¡BG¼ìºÅ¡M©Î¬OG¥X¦å¡C
¡m¬ü°êÂå¾Ç¨ó·|¤º¬ìÂå¾Ç¡n´Á¥Z(JAMA Internal Medicine)¥»¤ëµy¦®Éµoªí¬ã¨s³ø§i¡M¥¦»¡¡M¤H̪ø´ÁªA¥Î³oºØÃĪ«¡M¦³§ó°ª·ÀI¡M¥X²{ªº¯fªp¦³°©§é¡BªÍª¢¡B¹½®ñµß(C. difficile)¤ñ²v¼W¥[¡B§CÁâ¡BºC©ÊµÇ¯f¡C
º¡¦a¥i³Á°òº¸¤j¾ÇÂåÀø¤¤¤ß(McGill University Health Centre)¤º¬ìÂå¾Ç±M®a³Á§Jð¯ÇÂå¥Í(Dr. Emily McDonald)»¡¡R¡u³\¦h¬ã¨s³ø§i«ü¥X¡M¤j¬ù40%ªº¯f¤H¦b¨S¦³¹ê»ÚÃÒ¾Úªº±¡ªp¤UªA¥Î½è¤l¬¦§í¨î¾¯¡M«Ü¦h¯f¤H¨Æ«e¨S¦³¸Õ¥Î¨ä¥LÀøªk¡M¨Ò¦p§ïÅܥͬ¡¤è¦¡¡M©Î¬O±Ä¥ÎÃĤO¤ñ¸û·Å©MªºÃĪ«¡M©Î¸û¤Ö°Æ§@¥ÎÃĪ«¡C¡v
³Á§Jð¯ÇÂå¥Í«Øij¡M¦bªA¥ÎÃĪ««e¡M¥ý¥Î¨ä¥L¤èªk¹w¨¾G¨`¼ö¡M¨Ò¦p¡R¤Ö¦Y»Ä»¶¹ª«¡BÁ¡²ü¡N¥©§J¤O¡M¤£§l·Ï¡Q´î¤Ö°s¶q¡Q´N¹ì®É¡MÀY³¡µyµy¹Ô°ª¡Q¹¡¹«á¡M¤£°¨¤Wª×þH¡Q¥ý¥ÎÃÄ©Ê·Å©MªºÃĪ«¡M¦n¹³Tums ¡BRolaids¡M©Î²Õ´Ói²Ä¤G«¬¨üÅé§í¨î¾¯(histamine-2 receptor blockers)¡M¤£±o¤w¡M¤~ªA¥Î½è¤l¬¦§í¨î¾¯¡C